Spine devicemaker Carlsmed saw massive year-over-year leaps in its first quarter revenue, according to financial results posted May 5.
Five things to know:
1. First-quarter revenue reached $16.1 million, a 58% increase year over year.
2. Carlsmed saw gross profit of $12.4 million, up from $7.6 million during the same period in 2025.
3. Operating expenses grew to $21.7 million in the first quarter and include research and development, sales and marketing and general costs.
4. Carlsmed operated on a quarterly net loss of $8.7 million.
5. The company expects full-year 2026 revenue to be in the range of $72 million to $77 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
